These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36416121)

  • 1. Stability-Indicating RP-HPLC Method Development and Validation for Eltrombopag Olamine in the Presence of Impurities and Degradation Products. Robustness by Design of Expert Software.
    Dandabattina R; Subramanian VB; Merugu KS; SharathBabu H; Katari NK; Kowtharapu LP
    J AOAC Int; 2023 Mar; 106(2):267-275. PubMed ID: 36416121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study.
    Chinta SR; Chintala V; Nandimalla V; Ch R; Ediga SG; Kowtharapu LP; Katari NK
    J AOAC Int; 2024 Jan; 107(1):31-39. PubMed ID: 37758265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor.
    Demirhan T; Guksu E; Yazar Y; Keskin E; Bellur Atici E; Özkan SA
    J Pharm Biomed Anal; 2024 Jun; 243():116085. PubMed ID: 38471254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green Liquid Chromatography Method for the Determination of Related Substances Present in Olopatadine HCl Nasal Spray Formulation, Robustness by Design Expert.
    Kowtharapu LP; Katari NK; Sandoval CA; Muchakayala SK; Rekulapally VK
    J AOAC Int; 2022 Sep; 105(5):1247-1257. PubMed ID: 35686891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach.
    Subramanian VB; Katari NK; Dongala T; Jonnalagadda SB
    Biomed Chromatogr; 2020 Jan; 34(1):e4719. PubMed ID: 31634417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability-indicating reversed-phase-HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality-by-design approach.
    Subramanian VB; Katari NK; Ponnam V; Konduru N; Dongala T; Marisetti VM; Vyas G
    Biomed Chromatogr; 2022 Jan; 36(1):e5240. PubMed ID: 34486750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets.
    Azhakesan A; Kuppusamy S
    J AOAC Int; 2022 Mar; 105(2):370-378. PubMed ID: 34894249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of apalutamide-related substances method in solid dosage forms using HPLC.
    Bandaru LGR; Konduru N; Kowtharapu LP; Regulagadda S; Kanuparthy PR; Gundla R
    Biomed Chromatogr; 2023 Apr; 37(4):e5576. PubMed ID: 36573285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QBD-driven HPLC method of eltrombopag olamine: Degradation pathway proposal, structure elucidation, and in silico toxicity prediction.
    Jayagopal B; Murugesh S
    J Pharm Biomed Anal; 2021 Sep; 203():114231. PubMed ID: 34225039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a stability-indicating RP-HPLC method for the determination of fifteen impurities in rivaroxaban.
    Rao W; Li L; Zhang C; Zheng J; Fan X; Luan B; Sun J; Qiu M; Wu S; Li Y; Wang Z
    J Pharm Biomed Anal; 2023 May; 228():115325. PubMed ID: 36921446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
    Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
    Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by design (QbD) based development and validation of an HPLC method for amiodarone hydrochloride and its impurities in the drug substance.
    Karmarkar S; Yang X; Garber R; Szajkovics A; Koberda M
    J Pharm Biomed Anal; 2014 Nov; 100():167-174. PubMed ID: 25168215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
    Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
    Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.
    Vemuri DK; Gundla R; Konduru N; Mallavarapu R; Katari NK
    Biomed Chromatogr; 2022 Jun; 36(6):e5363. PubMed ID: 35292997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. User-Friendly HPLC Method Development and Validation for Determination of Enalapril Maleate and Its Impurities in Enalapril Tablets.
    Koppala S; Ranga Reddy V; Anireddy JS
    J Chromatogr Sci; 2017 Nov; 55(10):979-988. PubMed ID: 28985272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process.
    Cui D; Li Y; Lian M; Yang F; Meng Q
    Analyst; 2011 Aug; 136(15):3149-56. PubMed ID: 21695344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability-indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC-MS methods.
    Nagulancha BR; Lakka NS; Vandavasi KR
    Biomed Chromatogr; 2023 Aug; 37(8):e5644. PubMed ID: 37052118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets.
    Jeelani S; Soukhova N
    J Pharm Biomed Anal; 2021 Feb; 195():113858. PubMed ID: 33388642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.